Abstract
Ticarcillin has proved to be two- to fourfold more active than carbenicillin against most strains of Pseudomonas aeruginosa. Although susceptibility of the Enterobacteriaceae to ticarcillin could be predicted from results obtained with carbenicillin disks, neither the 50-μg nor the 100-μg carbenicillin disk proved suitable for testing susceptibility of P. aeruginosa to ticarcillin. Forty-three percent of Pseudomonas strains judged to be resistant to carbenicillin by the 100-μg carbenicillin disk were susceptible to ticarcillin by agar dilution studies. Results obtained with a 75-μg ticarcillin disk showed excellent correlation between zone size and ticarcillin minimal inhibitory concentration values and produced good discrimination between resistant and susceptible strains of Pseudomonas as determined by agar dilution studies. Using a 75-μg ticarcillin disk, a zone size of 12 to 14 mm was appropriate for designating intermediate susceptibility, and a zone greater than or equal to 15 mm was appropriate for designating susceptible strains of both P. aeruginosa and the Enterobacteriaceae.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Isenberg H. D., Siegel M. In vitro action of carbenicillin against bacteria isolated from clinical material. Appl Microbiol. 1969 Sep;18(3):387–392. doi: 10.1128/am.18.3.387-392.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Matsen J. M., Lund M. E., Brooker D. C. Comparison and evaluation of carbenicillin disks in diffusion susceptibility testing. Antimicrob Agents Chemother. 1974 Jun;5(6):599–606. doi: 10.1128/aac.5.6.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neu H. C., Garvey G. J. Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin. Antimicrob Agents Chemother. 1975 Oct;8(4):457–462. doi: 10.1128/aac.8.4.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neu H. C., Swarz H. Carbenicillin: clinical and laboratory experience with a parenterally administered penicillin for treatment of Pseudomonas infections. Ann Intern Med. 1969 Nov;71(5):903–911. doi: 10.7326/0003-4819-71-5-903. [DOI] [PubMed] [Google Scholar]
- Traub W. H., Raymond E. A. Interpretation of diffusion susceptibility data obtained with 50-mu g carbenicillin discs against gram-negative organisms. Appl Microbiol. 1971 Nov;22(5):862–864. doi: 10.1128/am.22.5.862-864.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Traub W. H., Raymond E. A. Susceptibility of Pseudomonas aeruginosa to carbenicillin. Appl Microbiol. 1970 Oct;20(4):630–632. doi: 10.1128/am.20.4.630-632.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Washington J. A., 2nd, Hall M. M., Fausch C. J., Brackin K. L. In vitro activity of carbenicillin against Pseudomonas using the disc diffusion method. Mayo Clin Proc. 1973 Oct;48(10):718–721. [PubMed] [Google Scholar]